Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
G Ital Nefrol ; 23 Suppl 36: S22-9, 2006.
Article in Italian | MEDLINE | ID: mdl-17068726

ABSTRACT

Acute renal failure (ARF) is highly incident among hospitalized patients, especially in intensive care units. ARF carries an independent and significant risk for increased mortality, morbidity, and health resources usage, both in the short- and the long-term perspective. Many controversies exist concerning the epidemiological and prognostic aspects of ARF. Key problems are the lack of a widely accepted ARF definition, the poor knowledge of the pathophysiological mechanisms of complications peculiar to ARF, and the unavailability of prognostic tools able to adequately express the medical complexity of the syndrome. These aspects are fundamental with regard to ARF prevention, a strategic goal in the approach to the syndrome; therefore, they will analyzed in depth in this review.


Subject(s)
Acute Kidney Injury , Critical Illness , Acute Kidney Injury/etiology , Acute Kidney Injury/physiopathology , Acute Kidney Injury/therapy , Humans , Prognosis
2.
G Ital Nefrol ; 23 Suppl 36: S38-45, 2006.
Article in Italian | MEDLINE | ID: mdl-17068728

ABSTRACT

Renal replacement therapies (RRT) are a key component of the therapeutic approach to acute renal failure (ARF) in the intensive care unit (ICU), and they are usually performed as classic Intermittent (intermittent hemodialysis) or continuous RRT (such as for example continuous venovenous hemofiltration, CVVH). No clear evidence exists on what the first-choice RRT option should be for ICU patients with ARF. Alternative strategies have been developed, under the form of intermittent prolonged RRT, with the aim of providing easy to perform, highly efficient, and less expensive RRT in the ICU. In this review we put forward the hypothesis that hybrid RRT, such as sustained low-efficiency dialysis ( sLED), could offer a valuable alternative to the currently available strategies in the critically ill with ARF.


Subject(s)
Acute Kidney Injury/therapy , Renal Dialysis/methods , Critical Illness , Humans
3.
G Ital Nefrol ; 23 Suppl 36: S112-9, 2006.
Article in Italian | MEDLINE | ID: mdl-17068738

ABSTRACT

Artificial nutrition in course of acute renal failure (ARF) is reviewed, on the basis of recent concepts on epidemiology and prognosis of the syndrome in critically ill patients. The relationships between nutritional status and ARF are evaluated, analyzing the possible role of nutritional status alterations as comorbidities and complications; pathogenetic mechanisms and consequences of hypercatabolism are described, with special regard to the peculiar metabolic derangements which are the hallmark of ARF. The effects of artificial nutrition on mortality and morbility in ARF are illustrated, along with quantitative and qualitative aspects of nutritional support (energy and protein needs, trace elements, vitamins etc). A rational approach to nutritional management of ARF patients is proposed, stressing the potential role of enteral nutrition, as well as the need for a full integration between nutritional support and renal replacement therapies.


Subject(s)
Acute Kidney Injury , Nutritional Support , Acute Kidney Injury/complications , Acute Kidney Injury/mortality , Acute Kidney Injury/pathology , Humans , Morbidity , Prognosis
4.
G Ital Nefrol ; 23 Suppl 36: S120-6, 2006.
Article in Italian | MEDLINE | ID: mdl-17068739

ABSTRACT

Critically ill patients with acute renal failure, and especially those with sepsis, may have increased coagulation changes as well as a high incidence of hemorrhagic complications. Thus, in this clinical condition, the use of renal replacement therapies (RRT) can be frequently complicated both by high rates of extracorporeal circuit coagulation, resulting in a reduced treatment efficacy, and by increased incidence of bleeding. Heparin is the most commonly used RRT anticoagulant, even if several alternative options have been proposed, aiming at obtaining regional anticoagulation (i.e., limited to the extracorporeal circuit). This review analyses modern strategies for RRT anticoagulation and evaluates safety and efficacy parameters of each method. In this regard, no definite recommendations can be made based on the available evidence further randomised controlled trials are needed in this field, with a clear endpoint definition.


Subject(s)
Acute Kidney Injury/therapy , Anticoagulants/therapeutic use , Renal Replacement Therapy , Blood Coagulation Disorders/drug therapy , Blood Coagulation Disorders/etiology , Hemorrhage , Heparin/adverse effects , Heparin/therapeutic use , Humans
5.
Clin Exp Immunol ; 133(2): 219-26, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12869027

ABSTRACT

Normal human immunoglobulin G (IgG) has anti-inflammatory and immuno-regulatory properties, which are exploited in the therapy of selected diseases. A putative mechanisms of action is the direct regulation of endothelial cell function by natural antiendothelial cell antibodies. Endothelium activation is a critical event in atherosclerosis. We have verified the ability of normal human IgG to modulate endothelial responses to the atherogenic stimuli tumour necrosis factor-alpha (TNFalpha) and oxidized low-density lipoproteins (oxLDL) in vitro. Confocal microscopy was used to visualize vascular cell adhesion molecule-1 (CD106) expression on endothelial cells, cytoplasmic free calcium ([Ca++]i) modifications and fluorescein-coupled oxLDL internalization. Cytokine secretion was measured by ELISA on cell supernatants. IgG prevented TNFalpha induced CD106 membrane expression and an increase in [Ca++]i, and inhibited the secretion of interleukin-6 (IL-6) and macrophage-colony-stimulating factor (M-CSF). IgG also inhibited CD106 expression induced by oxLDL and one pathway of their internalization, but were ineffective on oxLDL induced [Ca++]i rise and apoptosis. F(ab)'2 fragments from IgG, but not monoclonal IgG, reproduce IgG effects. These findings point to a regulatory role for specific antibodies included in circulating normal IgG towards proinflammatory responses of endothelial cells in atherogenesis and suggest possible development of new therapeutic strategies.


Subject(s)
Arteriosclerosis/metabolism , Endothelium, Vascular/drug effects , Immunoglobulin G/pharmacology , Lipoproteins, LDL/antagonists & inhibitors , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Apoptosis/drug effects , Calcium/metabolism , Cell Membrane/metabolism , Cell Survival/drug effects , Cells, Cultured , Cytokines/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/immunology , Humans , Interleukin-6/metabolism , Lipoproteins, LDL/pharmacology , Microscopy, Confocal , Monocytes/metabolism , Tumor Necrosis Factor-alpha/pharmacology
6.
Cancer ; 92(9): 2286-96, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11745283

ABSTRACT

BACKGROUND: The objective of this study was to evaluate response, toxicity, and immunologic effects of an original immunotherapy schedule based on repeated cycles of low doses of recombinant interleukin-2 (rIL-2) and recombinant interferon-alpha (rIFNalpha) in patients with metastatic renal cell carcinoma (mRCC). METHODS: Fifty patients who underwent nephrectomy received therapeutic cycles consisting of subcutaneous rIL-2 for 5 days per week and intramuscular rIFNalpha twice weekly for 4 consecutive weeks. The cycle was regularly repeated indefinitely at 4-month intervals in all patients, irrespective of their response. rIL-2 (1 x 10(6) IU/m(2)) was administered every 12 hours on Days 1 and 2 and once per day on Days 3-5 of each week; rIFNalpha (1.8 x 10(6) IU/m(2)) was given on Days 3 and 5. Toxicity was graded according to the World Health Organization (WHO) criteria. Forty percent of the patients had only one metastatic disease site at the time of treatment. The Kaplan-Meier method was used to estimate survival, and an analysis of variance was used to evaluate the effects on leukocytes and lymphocyte subsets over time. RESULTS: A total of 241 cycles were administered. One patient achieved a complete response, and five patients achieved a partial response. Five patients had stable disease, and 30 patients had progressive disease. Nine patients were not evaluable for response. The overall response rate was 12% (95% confidence interval, 3-21%) on the basis of an intent-to-treat analysis. The 36-month survival probability for all 50 patients was 47%. Treatment-related toxicity was limited to WHO Grades 1 and 2. Both lymphocyte and eosinophil levels significantly increased after all cycles (by 42% and 353%, respectively). The treatment also induced significant increases in the CD25 positive (24%), CD56 positive (28%), and CD3 negative/CD56 positive (54%) lymphocyte subsets. CONCLUSIONS: Long-term, repeated treatment with low doses of rIL-2 and rIFNalpha is feasible in patients with mRCC. The schedule induces clinical response rates and survival probabilities are similar to those obtained using higher doses.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Renal Cell/drug therapy , Carcinoma, Renal Cell/immunology , Interferon-alpha/pharmacology , Interleukin-2/pharmacology , Kidney Neoplasms/drug therapy , Kidney Neoplasms/immunology , Aged , Antineoplastic Agents/administration & dosage , Disease Progression , Drug Administration Schedule , Female , Humans , Immunotherapy , Injections, Intramuscular , Injections, Subcutaneous , Interferon-alpha/administration & dosage , Interleukin-2/administration & dosage , Killer Cells, Natural/immunology , Male , Middle Aged , Survival Analysis , Treatment Outcome
7.
In. Argentina. Ministerio de Obras y Servicios Públicos. Secretaría de Recursos Hídricos; UNESCO. Trabajos presentados. Buenos Aires, Secretaría de Recursos Hídricos, 1984. p.395-431.
Monography in Spanish | BINACIS | ID: bin-135841

ABSTRACT

Comenta sobre la importancia de las llanuras y afirma que de 950.000 km2, aproximadamente el 35 por ciento de la superficie continental corresponde a áreas de llanura y una gran parte presenta áreas inundables. Señala que el drenaje de las áreas inundables provoca cambios en el régimen hidrológico, que se vuelven decisivos en el desarrollo de las zonas a las que involucra y sobre el medio ambiente. El trabajo tiene por finalidad aportar un documento de base para un proyecto de hidrología de llanuras, con un enfoque interdisciplinario de otras especialidades, como geomorfología, hidrogeología, ecología, agronomía y otras disciplinas


Subject(s)
Argentina , Hydrology , Hydrogeology
SELECTION OF CITATIONS
SEARCH DETAIL
...